protein and peptide drug delivery system formulation and evaluation of delivery systems for proteins - Protein and peptide drug delivery systemM Pharm Protein and Peptide drug delivery system Advancing Therapeutics: A Deep Dive into Protein and Peptide Drug Delivery Systems

Barriers ofprotein and peptide drug delivery system The landscape of modern medicine is increasingly shaped by the therapeutic power of proteins and peptides. These complex biomolecules, comprising chains of amino acids, offer a high degree of specificity and efficacy in treating a wide array of conditions. However, their inherent fragility and susceptibility to degradation present significant hurdles in their effective drug administration. This is where the innovation in protein and peptide drug delivery systems becomes paramount, aiming to find an optimal way to deliver drugs to target tissues and organs, thereby maximizing their therapeutic potential.

Proteins and peptide-based drugs have great potential applications as therapeutic agents due to their ability to interact with biological targets with remarkable precision, often leading to higher efficacy and lower toxicity compared to traditional small molecule drugs. Conditions ranging from diabetes and cancer to immunological disorders and microbial infections can benefit from these advanced therapeutics. For instance, Proteins/peptides drugs can be used in the treatment of various diseaseslike cancer, diabetes, immunological disorders, and microbial infections.Protein and Peptide Drug Delivery The journey of protein and peptide drug delivery has seen remarkable progress, moving beyond conventional methods to sophisticated platforms designed to overcome biological barriers.

Historically, the administration of pharmaceutical proteins and peptides has largely relied on parenteral routes, such as intramuscular (IM), intravenous (IV), and subcutaneous injections. While these methods ensure direct entry into the bloodstream, bypassing the harsh environment of the gastrointestinal tract, they are often associated with patient discomfort, inconvenience, and the risk of infectionProtein and Peptide Drug Delivery - A Brief Review. This has fueled extensive research into alternative and more patient-friendly approaches, with a particular focus on oral and transdermal peptide drug delivery. The goal is to achieve comparable therapeutic outcomes with non-invasive methods, making treatment more accessible and improving patient compliance.

The challenges associated with delivering these delicate molecules are multifacetedScience behind GLP‑1 in a pill. Peptides are small proteins composed of up to a couple of dozen amino acids, and both proteins and peptides are prone to rapid degradation by digestive enzymes in the stomach and intestines.作者：N Thakur·2025·被引用次数：3—This study focuses on transdermal methods, summarizingrecent advancements in protein and peptide drug delivery. The transdermal route is ... Furthermore, their large molecular size and hydrophilic nature often hinder their passage across biological membranes. To address these limitations, there are various novel protein and peptide delivery systems being developed. These include advanced formulation and evaluation of delivery systems for proteins and macromolecules, with a strong emphasis on peptide-based drug delivery platforms. These platforms can manifest as peptide–drug conjugates, injectable biodegradable particles and depots for delivering small molecule drugs or the peptides themselves.PROTEIN AND PEPTIDE DRUG DELIVERY

Recent advancements have seen the emergence of innovative technologies such as prolease technology, nano-particulate and microparticulate delivery systems, mucoadhesive delivery of peptides, and microspheresA Current Review on Transdermal Delivery of Protein and .... These systems are engineered to protect the therapeutic agent from degradation, enhance its absorption, and control its release rate at the target site. For example, implanted polymeric devices are utilized in some cases. These devices are made by crosslinking polymers to create a matrix that slowly releases the protein or peptide over an extended period. Another significant area of development is the use of polyethylene glycol (PEG) in protein conjugation, a widely recognized strategy to improve the pharmacokinetic profile of protein drugs.作者：PK Deb·2019·被引用次数：83—There are various novel protein and peptide delivery systemsbeing developed for the purpose of providing improved delivery of therapeutic proteins and peptides ...

The exploration of non-invasive routes, particularly the oral route, remains a key focus.Protein and Peptide drug delivery system While the oral route is considered more convenient for drug administration, it presents substantial challenges due to the gastrointestinal environment作者：DK Malik·2007·被引用次数：320—Various delivery systems likeprolease technology, nano-particulate and microparticulate delivery system, mucoadhesive delivery of peptides and microspheres .... Research is actively exploring advanced oral drug delivery technologies that facilitate the protection and absorption of protein and peptide molecules.2018年10月13日—Protein and Peptide drug delivery systemare the Novel drug Delivery System. Proteins and peptides are the most abundant components of biological cells. Similarly, recent advancements in protein and peptide drug delivery are also revolutionizing the transdermal route, offering a needle-free alternative for systemic delivery.

In essence, the field of protein and peptide drug delivery system development is a dynamic and evolving areaThisreviewfocuses on the challenges and approaches involved in thedeliveryof these biomolecules through non-invasive routes.. It involves a multidisciplinary approach, combining expertise in pharmaceutics, biochemistry, and materials science to overcome inherent biological barriers and create effective therapeutic solutions. The ongoing review of these systems and the continuous pursuit of innovative delivery methods are critical to unlocking the full therapeutic potential of proteins and peptides, ultimately benefiting patients worldwide. The discovery of insulin in 1922 marked a pivotal moment, and since then, the field has expanded exponentially, with researchers constantly seeking new protein and peptide engineering and delivery strategies作者：VK Nikam·2022·被引用次数：4—Mostpharmaceutical proteins and peptidesare absorbed by IM,. IV and the Subcutaneous route of Absorption, but the oral route is better ....